New AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours.
The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported.
The AAnet AI tool, developed by the Sydney-based Garvan Institute of Medical Research in collaboration with the Yale School of Medicine in the US, uses deep learning to study gene activity in single cancer cells. It finds five different cell types within tumours, each with its own behaviour and risk of spreading. This helps doctors understand cancer better than older methods, which treated all tumour cells the same, said the multinational research team.
'Heterogeneity is a problem because currently, we treat tumors as if they are made up of the same cell. This means we give one therapy that kills most cells in the tumor by targeting a particular mechanism. But not all cancer cells may share that mechanism,' said the study's co-senior author, Associate Professor Christine Chaffer from the Garvan Institute.
As a result, some cancer cells survive, and the disease can return, Chaffer said.
She added that AAnet provides a way to biologically characterise tumour diversity, enabling the design of combination therapies that target all cell groups at once.
Associate Professor Smita Krishnaswamy of Yale University, a co-developer of the AI, indicated that this is the first method to distill cellular complexity into practical archetypes, potentially transforming precision oncology.
The technology is ready for clinical use, with plans to combine AI analysis and traditional diagnostics to create treatments tailored to each tumour's cell type.
Validated in breast cancer, it also shows promise for other cancers and autoimmune diseases, marking a shift toward personalised medicine, revealed the study published in the journal Cancer Discovery.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Meesho moves ahead with Rs 4,250cr IPO, shareholders approve listing plan and confidential filing route
Meesho representative image Bengaluru-based ecommerce marketplace Meesho has received shareholder approval to launch its initial public offering (IPO), aiming to raise Rs 4,250 crore (about $500 million) through a fresh issue of equity shares, according to filings with the Registrar of Companies. The approval was granted at an extraordinary general meeting of the company. The IPO will also include an offer for sale by some existing shareholders, as per ET. Meesho opts confidential IPO route Having recently shifted its domicile from the US to India, the e- commerce company plans to file the draft red herring prospectus with the securities and exchange board of India (SEBI) through the confidential route. Shareholders have also approved the appointment of founder Vidit Aatrey as chairman, managing director, and CEO. Institutional investors Elevation Capital, Peak XV Partners, and Prosus each hold 13–15% in Meesho, while Japanese investor SoftBank owns close to 10%. Other investors include WestBridge Capital and Fidelity. Meesho's last funding round raised $550 million, primarily through secondary transactions, valuing the company at around $3.9 billion, slightly below its peak valuation of $5 billion. That round included participation from Tiger Global, Think Investments, Mars Growth Capital, Peak XV, and WestBridge Capital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Sector 36 Gets a Sobha Makeover – Are You Ready to Upgrade? Sobha Realty Book Now Undo Regulatory filings also revealed that Meesho has expanded its 2024 employee stock option plan (Esop) by adding 1.1 million options, bringing the total to 7.5 million. A recent presentation by investor Prosus noted that Meesho handled over 1.8 billion orders in FY25, a 37% year-on-year growth from 1.3 billion in FY24. India's first horizontal e-commerce listing With the IPO, it is poised to become the first horizontal ecommerce company to list in India. Its competitor Flipkart is also shifting its domicile from Singapore to India in preparation for a planned IPO next year. Other internet-first and new-age companies preparing for public listings include Groww, Pine Labs, PhysicsWallah, Urban Company, Shiprocket, Boat, Wakefit, and Capillary Technologies. Omnichannel eyewear retailer Lenskart and logistics platform Shadowfax are also expected to file soon. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
2 hours ago
- Economic Times
Fashion tech startup Zilo raises $4.5 million from Info Edge Ventures, Chiratae Ventures
TIL Creatives Fashion tech startup Zilo has raised $4.5 million in a seed funding round co-led by Info Edge Ventures and Chiratae Ventures, as the company looks to expand its quick commerce model for urban fashion Mumbai-based startup plans to use the capital to strengthen its hybrid supply chain, deepen brand partnerships, and expand beyond Mumbai to other metro cities by the end of the year. Founded by Padmakumar Pal, a former senior executive at ecommerce platforms Flipkart and Myntra, and Bhavik Jhaveri, Zilo delivers fashion and lifestyle products from over 250 brands, including Levi's, Louis Philippe, Puma, and The Souled Store, in under 60 minutes. The company said it also offers scheduled home trials, instant returns, and AI-powered style recommendations."Zilo is creating a space which has the best blend of Online and Offline retail experiences, where speed, quality, and curation can coexist. The current landscape is cluttered, overwhelming and less reliable, especially for the discerning consumers who value both convenience and style," CEO Pal of the upcoming festive season, the company plans to expand into new categories such as footwear, bags, and accessories, and scale up to 100,000 styles across its platform.'Our other quick commerce investments have proven three constants for the consumer; speed sparks adoption, personalisation grows conversions and basket size, and trust in consistent delivery fuels loyalty and frequency,' said Kitty Agarwal, partner at Info Edge Ventures. 'Zilo aims to deliver on all three fronts with 60 minutes' delivery, Home Trials, instant returns, and a hand-picked curation of the best brands.' Zilo's fundraise comes amid rising interest in ultra-fast fashion delivery from both emerging brands and large ecommerce players. Brands such as Newme, Slikk, Blip, and Snitch, along with platforms such as Myntra and Ajio, are focusing on rapid delivery. Slikk recently raised $10 million in a round led by Nexus Venture Partners. Earlier this month, omnichannel menswear brand Snitch raised around $40 million in a round led by 360 One Asset (formerly IIFL Wealth & Asset Management). Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Profits plenty, prices attractive, still PSU stocks languish. Why? Why Sebi must give up veto power over market infra institutions Oil, war, and the Hormuz gambit: Why the 2025 standoff won't mirror the 2022 shock! Second only to L&T, but controversies may weaken this infra powerhouse's growth story Stock Radar: Titan Company bounces back after testing 200-DMA in June; breaks out from 1-month consolidation – what should investors do? Long- or medium-term investing: Invest in ability & balance sheet; 6 large-caps from different sectors, with upside potential of up to 36% Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports Plus These large- and mid-cap stocks can give more than 23% return in 1 year, according to analysts
India Today
2 hours ago
- India Today
Court orders preservation of dead man's semen as mother seeks it for lineage
The Bombay High Court has directed a Mumbai-based fertility centre to preserve the frozen semen of a 21-year-old cancer patient who died earlier this year, after his mother approached the court seeking to use it to continue the family's mother, a resident of Santacruz in Mumbai, told the court that her son had been diagnosed with Ewing sarcoma — a rare form of bone and soft tissue cancer. Before starting chemotherapy, his oncologist advised the family to freeze his semen as the aggressive treatment could affect his to the mother's petition, the family was confident the young man would recover, but were unaware that he had independently signed a consent form instructing the fertility centre to destroy his semen if he did not survive. The family, which now comprises only women following the deaths of the father and uncle, said the son was the sole male heir. The 21-year-old passed away on February 16 this year. Amid their bereavement, the family requested the fertility centre to transfer the preserved semen to a facility in Gujarat for further medical advice. However, the centre refused without a legal directive, citing the man's signed with no other option, the mother wrote to various government offices but received no response. She then filed a petition in the Bombay High plea came up before Justice Manish Pitale, who observed that the matter raises significant questions about how semen or gametes should be handled after the donor's death under the Assisted Reproductive Technology (Regulation) Act, 2021, and its rules. "This becomes particularly significant in the present case, for the reason that the deceased, being the son of the petitioner, was unmarried at the time of his death," Justice Pitale for the Union of India, Advocate Yashodeep Deshmukh referred to a pre-ART Act judgement of the Delhi High Court, where frozen semen was handed over to the parents of a person. However, he pointed out that unlike that case, the young man here had explicitly opted for disposal of his samples after his court also took note that in the Delhi High Court judgement, directions had been issued to the Ministry of Health and Family Welfare to consider framing appropriate laws or guidelines for posthumous sought time to verify whether any such guidelines now exist under the ART to ensure that the mother's plea does not become futile, the Bombay High Court ordered the fertility centre to preserve the frozen semen until the matter is decided.- EndsMust Watch
